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Nuclear actin polymerization is required
for transcriptional reprogramming of Oct4
by oocytes
Kei Miyamoto, Vincent Pasque, Jerome Jullien, and John B. Gurdon1
Wellcome Trust, Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge CB2 1QN, United Kingdom
Amphibian oocytes can rapidly and efficiently reprogram the transcription of transplanted somatic nuclei. To
explore the factors and mechanisms involved, we focused on nuclear actin, an especially abundant component of
the oocyte’s nucleus (the germinal vesicle). The existence and significance of nuclear actin has long been debated.
Here, we found that nuclear actin polymerization plays an essential part in the transcriptional reactivation of
the pluripotency gene Oct4 (also known as Pou5f1). We also found that an actin signaling protein, Toca-1,
enhances Oct4 reactivation by regulating nuclear actin polymerization. Toca-1 overexpression has an effect on the
chromatin state of transplanted nuclei, including the enhanced binding of nuclear actin to gene regulatory regions.
This is the first report showing that naturally stored actin in an oocyte nucleus helps transcriptional
reprogramming in a polymerization-dependent manner.
[Keywords: nuclear actin; transcriptional reprogramming; Xenopus oocyte; Oct4; Toca-1]
Supplemental material is available for this article.
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Differentiated cell states are stable. Once cell types are
established, they hardly ever change to other cell types in
normal development. However, several experimental
approaches enable differentiated cells or nuclei to gener-
ate primitive embryonic cells that can redifferentiate into
every cell type in a body. These include nuclear transfer
(NT) to eggs/oocytes and induced pluripotent stem (iPS)
cells (Gurdon andMelton 2008; Jaenisch and Young 2008).
Mechanistic insights into these reprogramming processes
are still elusive, although it is known that induced pluri-
potency can be initiated by defined transcription factors
(Takahashi and Yamanaka 2006). Eggs/oocytes reprogram
somatic cells more efficiently than the iPS procedure (Kim
et al. 2010; Pasque et al. 2010). However, only a few
reprogramming factors of eggs or oocytes have been iden-
tified so far (Tamada et al. 2006; Jullien et al. 2010).
Our aim is to identify reprogramming factors and
mechanisms that eggs/oocytes naturally possess. How-
ever, reprogramming to pluripotency by eggs or iPS cells
is a complicated process accompanied by many cell di-
visions. These often mask direct effects of reprogram-
ming factors, and hence a stochastic model for iPS re-
programming has been proposed (Hanna et al. 2009;
Yamanaka 2009). Numerous cell divisions can also ob-
scure the role of a reprogramming factor (Smith et al.
2010). Therefore, a system without cell division is desir-
able, especially for the purpose of revealing a mechanistic
insight into reprogramming. One crucial event during
reprogramming is the reactivation of silenced pluripo-
tent/embryonic genes such as Oct4 (Boiani et al. 2002;
Stadtfeld et al. 2008; Kim et al. 2009). A direct way to
induce the transcriptional activation of Oct4 by oocyte
factors is NT into Xenopus laevis oocytes at the germinal
vesicle (GV) stage. In this type of NT, no cell division and
no new protein synthesis is required before repro-
grammed transcripts are detected (Byrne et al. 2003;
Gurdon andMelton 2008), and the magnitude of transcrip-
tion reaches a level equal to that of a fully transcribed state
when certain cell types are used (Jullien et al. 2010).
In the current study, we focused on actin in an oocyte
nucleus (nuclear actin) as a candidate reprogramming
factor because our preliminary fractionation of repro-
gramming-related factors in oocyte extracts identified
several nuclear actin-interacting proteins. Actin is amajor
component of the cytoskeleton and plays fundamen-
tal roles in many biological processes. However, large
amounts of actin have been also found in a nucleus,
including the GVof Xenopus oocytes (Clark andMerriam
1977). Recently, several groups have obtained evidence
for actin having a functional role in the nucleus. This
includes the finding that nuclear actin is engaged in
transcription by all three RNA polymerases (Visa and
Percipalle 2010), and the finding that many chromatin
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remodeling complexes are associated with actin (Zhao
et al. 1998;Olave et al. 2002; Bettinger et al. 2004). However,
it remains unclear whether nuclear actin is involved in
gene reactivation, and its involvement in reprogramming
processes has never been examined. Here, we found that
nuclear actin polymerization, naturally occurring in the
oocyte nucleus, is necessary for transcriptional repro-
gramming of Oct4 from transplanted somatic nuclei.
Results
Nuclear filamentous actin is formed
in transplanted nuclei
Xenopus oocytes contain massive amounts of nuclear
actin, which constitutes;6% of the total nuclear protein
and is at a concentration of at least 2 mg/mL in the GV
(Clark and Merriam 1977); the filamentous form of actin
(F-actin) is observed in the GV (Bohnsack et al. 2006). We
tested whether F-actin is formed in the nuclei of mouse
cells transplanted into oocytes. A live-cell imaging
method to visualize F-actin was developed in order to
follow the dynamics of actin polymerization. Green fluo-
rescent protein (GFP)-tagged F-actin probes based on the
calponin homology domain of utrophin (GFP-UtrCH),
which contains a F-actin-binding domain, faithfully
marks the distribution of F-actin without changing the
balance of actin assembly/disassembly (Burkel et al.
2007). GFP-UtrCH was expressed in oocytes by mRNA
injection before NT (Fig. 1A).
GFP-UtrCH protein was detected in both the cyto-
plasm and the GV of oocytes (Supplemental Fig. S1A). In
the GV, a meshwork structure of nuclear actin, as was
reported by Bohnsack et al. (2006), was observed by the
GFP-UtrCH probe (Fig. 1B). RFP-histone B4 or Cherry-
histone H2B mRNA was coinjected to visualize the
injected somatic nuclei. Nuclear actin was abundant
around the injected nuclei (Supplemental Fig. S1B, white
dotted area). Localization of actin at the nuclear periphery
was observed at 3 h after NT, becoming stronger after
further culture (Supplemental Fig. S1C, white arrows at
3 h and 16 h). This actin localization overlapped with
nuclear lamin B1, especially in the outer region of lamin
B1 (Supplemental Fig. S2A, yellow color on the merge
photo), indicating that perinuclear F-actin is formed on
the nuclear envelope. This link is further supported by
the observation that perinuclear actin localization dis-
appeared in the area where the nuclear envelope had
Figure 1. Visualization of nuclear F-actin. (A) Schematic diagram of the experimental strategy to visualize nuclear F-actin formed in
transplanted nuclei. Injected nuclei cannot be observed without dissecting GVs. Dissected GVs can be maintained alive in mineral oil
and are transparent enough to observe their interior structure by confocal microscopy. (B) Nuclear F-actin in a Xenopus oocyte nucleus,
visualized with GFP-UtrCH probes. A meshwork structure of nuclear F-actin is naturally formed in nucleoplasm. Bar, 5 mm. (C)
Nuclear F-actin is observed in injected nuclei. F-actin was labeled with GFP-UtrCH (green) and chromatin of injected nuclei was
visualized with Cherry-histone H2B (red). Actin bundles in a transplanted nucleus are marked with white arrows. The image was taken
24 h after NT. Bar, 10 mm.
Nuclear actin and gene reprogramming
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broken down (Supplemental Fig. S2A, arrows). At 24 h
after NT, filamentous nuclear actin was observed in the
transplanted nuclei (Fig. 1C; Supplemental Fig. S1C, red
arrows at 24 h). Actin bundles were formed inside the
circular chromatin (Fig. 1C, arrows), and actin filaments
around and in the transplanted nuclei were mobile
(Supplemental Movie S1).
We next asked whether differences in the donor nuclear
states affected nuclear actin formation. The nuclei of
embryonic stem (ES) cells were injected as representative
of undifferentiated cells. ES nuclei swelled more easily
than C2C12 nuclei and were more extensively dispersed.
Slightly more abundant actin filaments were observed in
ES nuclei than in C2C12 nuclei (Supplemental Fig. S2B).
This indicates that nuclei of ES cells, which have the
greatest transcriptional plasticity, exhibit abundant nu-
clear actin formation when transplanted to oocytes.
To confirm thatGFP-UtrCH faithfully recognizes F-actin,
GVs with transplanted nuclei were fixed and stained
with phalloidin-TRITC, which specifically marks F-actin.
Phalloidin staining resulted in a pattern of F-actin forma-
tion similar to that visualized by GFP-UtrCH probes
(Supplemental Fig. S3A). As a control, F-actin in cultured
C2C12 cells before NT was also stained by the same
method, but such nuclear F-actin formation was not
observed (Supplemental Fig. S3B). In conclusion, F-actin
is present in nuclei transplanted into Xenopus oocytes,
although it takes;24 h to see a detectable level of nuclear
F-actin. This delay in appearance of nuclear actin may
be because transplanted somatic nuclei have inherited
a mechanism to export actin (Stuven et al. 2003), and/or
because no active import mechanism for nuclear actin
exists in injected nuclei. The strong perinuclear localiza-
tion of nuclear actin might reflect this active export
(Supplemental Fig. S1C). More interestingly, the timing
of nuclear actin appearance is correlated with the time
when reprogrammed transcripts start to be detected
(Halley-Stott et al. 2010).
Nuclear actin polymerization is required
for transcriptional reactivation of Oct4
We examined whether polymerized nuclear actin is
important for transcriptional reactivation by several
different methods (Supplemental Fig. S4A). To inhibit
nuclear actin, a monoclonal antibody against b-actin
(clone AC15) that recognizes the N-terminal region of
b-actin was injected into the GV with donor C2C12
nuclei. Forty-eight hours after NT, Oct4 reactivation
was significantly inhibited (P = 0.0029; fivefold down)
by AC15 injection (Fig. 2A). This antibody specifically
and robustly recognizes nuclear b-actin in GVs and shows
a stronger inhibition than another anti-bactin antibody
(clone AC40) (data not shown). To check the effect of
antibody injection on actin polymerization, nuclear F-actin
in the antibody-injected oocytes was visualized by GFP-
UtrCH probes. As expected, less F-actin was found in the
NToocytes coinjected with AC15 (Supplemental Fig. S4B).
Several actin mutants that do not polymerize (G13R
and R62D) or that enhance polymerization (G15S and
S14C) have been reported (Posern et al. 2002, 2004). We
expressed these actin mutants in oocytes by mRNA
injection, and somatic nuclei were subsequently injected
(Supplemental Fig. S4A [panel ii],C). The mutant that
enhances polymerization, G15S, significantly enhanced
(P = 0.025)Oct4 reactivation by sixfold (Fig. 2B, black bar).
The stronger effect of G15S on Oct4 reactivation com-
pared with S14C may be explained by the fact that G15S
has a higher affinity to bind actin-associated nucleotides
than S14C (Posern et al. 2004). In contrast, actin mutants
unable to polymerize did not increase Oct4 reactivation,
but R62D rather reduced the reactivation by more than
twofold (Fig. 2B, gray bar). The difference between R62D
and G15S inOct4 reactivation was 14-fold. These results
indicate that actin polymerization is important for Oct4
gene reactivation.
We next inhibited actin polymerization by the actin-
depolymerizing drug cytochalasin B (CB) during incuba-
tion of NT oocytes (Supplemental Fig. S4A, panel iii).
Treatment with CB greatly reduced polymerized actin in
GVs (Supplemental Fig. S4D), although a faint signal of
GFP-UtrCH could still be detected if detection gain was
increased. CB treatment also reduced Oct4 reactivation
(down to 50% 48 h after NT) (Fig. 2C).
Actin is known as an inhibitor of DNaseI. Therefore, it
is possible that transplanted nuclei are somewhat de-
graded by endogenous DnaseI, and changing actin poly-
merization could affect this DNaseI activity. As a result,
increased Oct4 transcription would be detected after
increasing actin polymerization and vice versa. We tested
this possibility by examining the integrity of the DNA of
injected nuclei using the same quantitative PCR (qPCR)
primers as for the transcription assay (Supplemental Fig.
S5). During the culture of NT oocytes, no significant
DNA degradation was observed (Supplemental Fig. S5A).
Furthermore, changing the amount of polymerized actin
in the GV (discussed in the next section) did not influence
DNA degradation, at least on the region examined for the
transcriptional reprogramming assay (Supplemental Fig.
S5B). These results indicate that altered Oct4 expression
after changing nuclear actin polymerization is not attrib-
utable to altered DNaseI activity in degrading injected
DNA.
Even though evidence that nuclear actin is important
forOct4 reactivation has been obtained, we still could not
exclude the involvement of cytoplasmic actin-mediated
pathways in gene reactivation. Isolated Xenopus GVs can
be cultured in mineral oil without losing transcriptional
reprogramming activity (Jullien et al. 2010), so that repro-
gramming is achieved entirely by oocyte GV components.
After isolation of GVs, nuclei were injected with CB or
DMSO, a vehicle of CB (Supplemental Fig. S4A, panel iv).
We injected 50 mg/mL CB per 10 nL into the GVs, which
depolymerized almost all actin in GVs (Bohnsack et al.
2006). After a 48-h incubation, Oct4 reactivation was
detected in control samples (Fig. 2D, CB), but a threefold
reduction was seen when CB was included (Fig. 2D). CB
binds to the barbed end of polymerized actin, inhibits
further polymerization, and results in an increased pro-
portion of monomeric actin (G-actin). If G-actin binds to
Miyamoto et al.
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an activator of Oct4 and sequesters it like the transcrip-
tional coactivator MAL (Vartiainen et al. 2007), increased
G-actin would cause down-regulation ofOct4. To exclude
this possibility, we repeated the oil GV experiment with
another actin-depolymerizing reagent, latrunculin A
(LA), which binds to G-actin and inhibits polymerization.
This again led to a striking inhibition of transcriptional
reactivation of Oct4 by 17-fold (P = 0.0016) (Fig. 2E). In
conclusion, nuclear actin polymerization is necessary for
the reactivation of the silenced Oct4 gene in oocytes.
An actin signaling protein, Toca-1, regulates
Oct4 reactivation
We showed here a requirement of actin polymerization
for strong Oct4 reactivation by modulating nuclear actin
polymerization. However, one possibility is that Oct4
reactivation is inhibited by secondary nonspecific effects,
because antibody injection and chemical treatment may
have a range of pleiotropic effects. To exclude this possi-
bility, it is important to find a specific upstreammolecule
that regulates nuclear actin polymerization and Oct4
reactivation. The dynamics of actin polymerization are
regulated by actin nucleators and actin signaling proteins.
These factors are localized mainly in the cytoplasm, but
some reports suggest that several actin nucleators are
present in nuclei, although little is known about their
function (Percipalle 2009). We tested four such factors—
Toca-1 (Ho et al. 2004), N-WASP (Wu et al. 2006), Rac1
(Eden et al. 2002), and JMY (Zuchero et al. 2009)—to ask
whether they play a role in a reprogramming context.
These factors were overexpressed as HA-tagged proteins
in oocytes by mRNA injection before NT (Fig. 3A). They
were all expressed in GVs, although only a low level
of JMY was detected (Fig. 3B). As a control, different
amounts of these proteins were expressed by injecting
various amounts of mRNA (1.5, 4.6, or 13.8 ng). All
factors, except for N-WASP, enhanced Oct4 reactivation
in transplanted C2C12 nuclei by up to fourfold, but only
Toca-1 injection with 4.6 and 13.8 ng of mRNA showed a
statistically significant and dose-dependent positive effect
(P = 0.024 and 0.014, respectively) onOct4 transcriptional
Figure 2. Nuclear actin polymerization is necessary for transcriptional reprogramming of Oct4. (A) Anti-bactin antibody injection
(clone AC15) into GVs inhibits the transcriptional reactivation of Oct4 in NT oocytes. IgG was injected as a control. Relative fold
increases of gene transcripts to control NTwere measured by qPCR. Transcription was analyzed 24 h and 48 h after NT. Data represent
mean 6 SEM; (**) P = 0.0029; F and T-test against control, antibody injection: n = 8 at 48 h and n = 5 at 24 h; control injection: n = 4 at
48 h and n = 2 at 24 h. (B) Actin mutant expression influences transcriptional reactivation of Oct4 in NT oocytes. Several human actin
mutants (G13R, R62D, G15S, and S14C) and human wild-type actin (wt) were expressed in oocytes, and these oocytes were used for NT.
Transcript level is relative to control wild type. Data represent mean 6 SEM; (*) P = 0.025; F and T-test against wild type, n = 6. (C) The
effect of actin-depolymerizing reagent onOct4 reactivation in NToocytes. CB was added to culture medium at a concentration of 5 mg/
mL during 48 h of culture. Data represent mean6 SEM; CB+: n = 10 at 48 h and n = 4 at 24 h; control: n = 11 at 48 h and n = 4 at 24 h. (D)
Oct4 reactivation from transplanted nuclei is inhibited by depolymerizing nuclear actin with CB in oil GVs. Nuclei suspended in CB-
containing solution (gray bar, CB+) or DMSO-containing solution (black bar, CB) were injected into oil GVs, and transcriptional
activation was examined by qRT–PCR analysis. Transcript level is relative to control CB. Data represent mean 6 SEM; n = 6. (E)Oct4
reactivation from transplanted nuclei is inhibited by depolymerizing nuclear actin with LA in oil GVs. Nuclei suspended in LA-
containing solution (gray bar, LA+) or DMSO-containing solution (black bar, LA) were injected into oil GVs. Data represent mean 6
SEM; (**) P = 0.0016; F and T-test against LA; n = 3.
Nuclear actin and gene reprogramming
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reactivation (Fig. 3C). Other pluripotency-related genes
(Sox2, Klf4, c-myc, Nanog, and Lefty1) and genes highly
expressed in donor cells (c-Jun and Gapdh) were not
influenced by TOCA-1 overexpression (Fig. 3C), suggest-
ing a specific effect of TOCA-1 onOct4. Remarkably, this
positive effect of TOCA-1 on Oct4 reactivation was
Figure 3. An actin signaling protein, Toca-1, enhancesOct4 reactivation. (A) Schematic diagram of the experimental strategy to assess
the effect of actin nucleators and actin signaling proteins on transcriptional reprogramming from transplanted C2C12 nuclei. (B) Four
factors tagged with HA are expressed as proteins in both the GV and cytoplasm. These include Xenopus tropicalis JMY (xtJMY), X.
tropicalis TOCA-1 (xtTOCA-1), mouse N-WASP (mN-WASP), and X. laevis RAC1 (xlRAC1). The proteins were detected by Western
blot analysis using anti-HA antibody 24 h after mRNA injection. Actin was used as a loading control. (C) The effect of overexpression of
the actin polymerization regulator on transcriptional reprogramming. Relative fold increases of gene transcripts to control water-
injected samples are shown, measured by qPCR. Data represent mean 6 SEM; (*) P < 0.05; F and T-test against the control water
injection; n = 4. (D) A mutant form of Toca-1, Toca-1(W518K), does not enhanceOct4 reactivation, while wild-type Toca-1 enhances it.
Toca-1(W518K) was similarly overexpressed in oocytes by mRNA injection. Relative fold increases of gene transcripts to control water-
injected samples are shown, measured by qPCR. Data represent mean 6 SEM; (*) P = 0.018; F and T-test against the control; Toca1:
n = 3; others: n = 4). (E) Reactivation of Oct4, Gdf3, and Eif4e1b genes was enhanced by the overexpression of TOCA-1. Gdf3
is a pluripotency gene and Eif4e1b is an oocyte-specific gene. Data represent mean6 SEM; (**) P < 0.02; (*) P < 0.05; F and T-test against
the control; n = 5–6).
Miyamoto et al.
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abrogated by overexpressing the point mutation of TOCA-
1(W518K), which is unable to promote actin polymeriza-
tion (Fig. 3D; Ho et al. 2004).
Since TOCA-1 has a selective effect on Oct4 reactiva-
tion, we investigated other genes whose reactivation is
enhanced by TOCA-1 overexpression in the same way as
Oct4. We checked a list of pluripotency genes that change
epigenetic modifications in the same way as Oct4 dur-
ing reprogramming (Mikkelsen et al. 2008). In addition,
oocyte-specific genes are known to be reactivated in our
system (Tamada et al. 2006). Thus,Gdf3 and Eif4e1bwere
selected as a pluripotent gene and an oocyte-specific gene,
respectively. The effect of TOCA-1 overexpression on the
reactivation of these genes was examined. Gdf3 and
Eif4e1b were expressed very little in C2C12 cells, but
were reactivated after NT to Xenopus GVs (data not
shown). The transcription of these genes and Oct4 was
significantly enhanced by TOCA-1 (Fig. 3E). The positive
effect of Toca-1 is not limited to Oct4.
We next examined whether TOCA-1 localizes to trans-
planted C2C12 nuclei. Nuclei were transplanted into
Toca1-Cherry and GFP-UtrCH mRNA-injected oocytes
and observed by the oil GV procedure. TOCA1-CHERRY
was detected in GVs and injected nuclei (Fig. 4A, white
arrow). TOCA-1 was present in the GV and was prefer-
entially localized in the area where F-actin is abundantly
detected. Some nuclei in which Toca1-Cherry was not
present did not show filamentous actin (Fig. 4A, blue
arrow). To confirm that endogenous TOCA-1 is present in
the GV, a Western blot was performed. TOCA-1 was
present in the Xenopus oocyte cytoplasm and also at
a weaker level in the GV, which is 20 times smaller in
Figure 4. Toca-1 exists in a transplanted nucleus and enhances nuclear actin polymerization. (A) TOCA1-CHERRY is present in
injected nuclei. Toca1-Cherry and GFP-UtrCH mRNA were injected before NT. The injected nuclei were observed 48 h after NT by
confocal microscopy using the oil GV method. A nucleus in which TOCA1-CHERRY is present shows nuclear F-actin formation (white
arrow). In contrast, nuclear F-actin is not detected in a nucleus without TOCA1-CHERRY (blue arrow). Bar, 20 mm. (B) TOCA1
overexpression increases nuclear F-actin formation. Different amounts of TOCA1 were expressed in oocytes by mRNA injection with
different concentrations. These injected oocytes were used for NT. The oocytes were subjected to immunofluorescence analysis and
phalloidin staining 48 h after NT. Images were obtained from randomly selected areas. Nuclear F-actin amounts were quantified using
the ImageJ software (Materials and Methods). Statistical differences were measured by F and T-tests. Data represent mean 6 SEM; Toca-1
1.5 ng: n = 45; Toca-1 4.6 ng and 13.8 ng: n = 55. (C) Actin fractionation experiment indicates that TOCA-1 overexpression increases
the F-actin population in GVs. TOCA-1 was expressed in oocytes by mRNA injection. GVs were collected from these injected oocytes
or noninjected oocytes, and total actin was fractionated to monomeric and polymeric actin (G- and F-actin, respectively). The amounts
of G- and F-actin were measured by Western blot analysis using anti-bactin antibody. CB was added to culture medium at a 1 mg/mL
concentration to check that enhanced actin polymerization was diminished with this concentration. F-actin proportion in total actin
was compared among three samples, and fold differences relative to the control noninjected oocytes (Toca and CB) are shown. Data
represent mean 6 SEM; n = 2. (D) Actin fractionation experiment indicates that overexpression of a TOCA-1 mutant, W518K, does not
increase the F-actin population in GVs. F-actin ratio in total actin is relative to control water-injected oocytes. Data represent mean 6
SEM; n = 2.
Nuclear actin and gene reprogramming
GENES & DEVELOPMENT 951
 Cold Spring Harbor Laboratory Press on May 3, 2011 - Published by genesdev.cshlp.orgDownloaded from 
volume than the cytoplasm (Supplemental Fig. S6A).
Immunoprecipitation of TOCA-1 from Xenopus GV ex-
tracts confirmed that TOCA-1 is also in the GV, although
it is not abundant (Supplemental Fig. S6B). Immunofluo-
rescence analysis was carried out in order to see locali-
zation of endogenous TOCA-1 in transplanted nuclei.
Endogenous TOCA-1 was present throughout the GV,
including in transplanted nuclei (Supplemental Fig. S6C).
We finally examined the effect of TOCA-1 overexpres-
sion on actin polymerization using phalloidin staining
and image analysis (Materials and Methods). Injection of
4.6 ng and 13.8 ng of Toca-1 mRNA significantly in-
creased nuclear F-actin formation compared with 1.5-ng
injection (Fig. 4B), correlating well withOct4 reactivation
data (Fig. 3C). An actin fractionation experiment also
showed that the proportion of nuclear F-actin increased
after TOCA-1 overexpression (Fig. 4C), and, as expected,
the mutant form of TOCA-1(W518K) did not increase the
relative proportion of F-actin (Fig. 4D). Our results
demonstrate that TOCA-1 enhances nuclear actin poly-
merization and Oct4 transcriptional reactivation.
Nuclear actin is important for both continuing
transcription and the transcriptional reprogramming
of Oct4
Here we showed a requirement of nuclear actin polymer-
ization for Oct4 reactivation and of an upstream mole-
cule, Toca-1, for this event. We next asked whether
nuclear actin is involved in ongoing transcription of
Oct4 as well as in its reprogramming processes. Two
experiments were designed to test this. First, as depicted
in Supplemental Figure S4A (panel i), the anti-bactin
antibody was injected into a GV with ES nuclei in which
Oct4 was already continuously expressed. Oct4 tran-
scription from transplanted ES nuclei was significantly
inhibited (P = 0.0076) by the antibody injection (Fig. 5A).
Since transcriptional reprogramming is not required for
continuousOct4 expression from transplanted ES nuclei,
nuclear actin is involved in the ongoing transcription of
Oct4. Second, we asked whether TOCA-1 overexpression
enhances continuous Oct4 expression in transplanted ES
nuclei. Although TOCA-1 reproducibly enhanced Oct4
reactivation in transplanted C2C12 nuclei using the same
batch of oocytes, the continuousOct4 transcription from
transplanted ES nuclei was not affected by TOCA-1 (Fig.
5B). This result indicates that TOCA-1-mediated actin
polymerization accelerates a reprogramming process, but
does not affect ongoing transcription. We conclude that
nuclear actin, but not Toca-1, is involved in both ongoing
transcription and reprogramming.
Nuclear actin polymerization and
chromatin remodeling
Increased nuclear actin polymerization enhances Oct4
reactivation. We asked whether nuclear actin polymeri-
zation could affect the chromatin states of transplanted
nuclei. We carried out coimmunoprecipitation analysis to
ask whether oocyte nuclear actin was bound to chromatin
proteins related to transcription and reprogramming (Zhao
et al. 1998; Bettinger et al. 2004; Hofmann et al. 2004; Dion
et al. 2010). This revealed that nuclear actin was bound to
RNA polymerase II (Pol II) and the BAF complex (Fig. 6A).
Immunofluorescence analysis also showed colocalization
of nuclear actin and elongating Pol II (data not shown).
These results suggest that actin in the GV may play a role
in not only transcription, but also chromatin remodeling.
We sought to perform quantitative chromatin immu-
noprecipitation (qChIP) analysis in order to see an effect
of nuclear actin polymerization on chromatin. However,
ChIP using NToocytes is technically challenging because
it requires numerous transplanted nuclei. To detect the
binding of nonhistone chromatin proteins like remodeling
complexes, we used a transgenic ES cell line that pos-
sesses ;30 copies of the Oct4 regulatory region driving
Figure 5. Nuclear actin polymerization is impor-
tant for both ongoing transcription and transcrip-
tional reprogramming of Oct4. (A) Anti-bactin
antibody injection into GVs inhibits Oct4 transcrip-
tion from transplanted ES nuclei. IgG was injected as
a control. Relative fold increases of gene transcripts
to control NT were measured by qPCR. Transcrip-
tion was analyzed 48 h after NT. Data represent
mean 6 SEM; (**) P = 0.0076; F and T-test against
the control; n = 5. (B) TOCA-1 overexpression does
not enhance Oct4 transcription from transplanted
ES nuclei, while it enhancesOct4 transcription from
C2C12 nuclei. Transcript level is relative to control
water-injected samples. Data represent mean 6
SEM; ES nuclei: n = 4; C2C12 nuclei: n = 3.
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Neomycin resistance gene (Neo) expression (Supplemen-
tal Fig. S7A). After retinoic acid differentiation, the
retinoic acid-treated ES cells (RA-ES cells) showed strong
down-regulation of Neo, indicating a silencing of the
transgenic Oct4 promoter (Supplemental Fig. S7B). Si-
lenced Neo expression in RA-ES cells was reactivated
after NT, and reactivation was enhanced by TOCA-1
overexpression (Supplemental Fig. S7C). Furthermore,
the enhanced Neo expression was inhibited by adding 1
mg/mL CB during incubation of NT oocytes (Supplemen-
tal Fig. S7C), and this concentration of CB abolished
increased actin polymerization by TOCA1 (Fig. 4C). These
results indicate that the transgenicOct4 promoter behaves
like the endogenous Oct4 promoter.
The binding of nuclear actin to the Oct4 upstream
region was examined by qChIP analysis. AC15 antibody
was used because our preliminary data suggested its pre-
cipitation ability was stronger than another anti-bactin
antibody (A2103, Sigma) that also recognizes theN-terminal
region, and because it has been used for ChIP analysis
(Ambrosino et al. 2010; Xu et al. 2010). Nuclear actin
binding to the Oct4 regulatory region and gene body was
observed, and TOCA-1 overexpression enhanced its bind-
ing by up to 10-fold (Fig. 6B). The gene body examined
here is located close to the polyadenylation site of the
Oct4 gene. These results suggest that TOCA-1 enhances
the binding of nuclear actin to Oct4. We also examined
Pol II and BAF complex binding after TOCA-1 over-
expression. Pol II binding to the Oct4 gene was slightly
increased by TOCA-1 overexpression (Supplemental Fig.
S8A), implying that TOCA-1 weakly affects Pol II local-
ization in our system. For ChIP analysis of the BAF
complex, BAF57 antibody was used because it is highly
conserved in the complex among many species (Ho and
Crabtree 2010). TOCA-1 overexpression induced an ap-
proximately twofold greater BAF57 binding in the Oct4
regulatory region (Supplemental Fig. S8B). Together, the
effect of TOCA-1 overexpression on chromatin binding
appeared strongly in nuclear actin, modestly in the BAF
complex, and weakly in Pol II. In conclusion, TOCA-1
overexpression, accompanied by enhanced nuclear actin
polymerization, entails rearrangement of chromatin-
binding proteins. These results do not explain all of the
positive effects of TOCA-1 overexpression on Oct4 reac-
tivation, but the enhanced access of chromatin factors by
TOCA-1 might be one explanation for this positive effect.
Discussion
Nuclear actin was found >30 years ago. Early studies also
showed its involvement in the expression of protein-
coding genes (Scheer et al. 1984). However, the signifi-
cance of these findings has been questioned for a long
time. One of the major reasons for this skepticism is that
the actin filaments normally observed in the cytoplasm
could not be visualized in the nucleus. Nevertheless,
recent studies provided convincing evidence for nuclear
actin (McDonald et al. 2006) and its role in nuclear
processes (Visa and Percipalle 2010). One elegant contri-
bution showed that a nuclear actin mesh is formed in the
giantXenopus oocyte nucleus (Bohnsack et al. 2006). This
nuclear F-actin scaffold is required to support mechanical
integrity of the giant nucleus. We extended this view
using live-cell imaging. The F-actin in transplanted
nuclei undergoes a global change during reprogramming,
and the timing of nuclear actin formation is positively
correlated with transcriptional reprogramming.
Nuclear actin is involved in transcription by all three
RNA polymerases (Hofmann et al. 2004; Hu et al. 2004;
Philimonenko et al. 2004), and in transcriptional initia-
tion after cytokine stimulation (Hofmann et al. 2004) and
retinoic acid treatment (Ferrai et al. 2009). Although
there is evidence for actin’s involvement in transcription,
in vivo evidence is still lacking. In addition, these results
are accompanied by concerns about contamination and
involvement of cytoplasmic actin. Considering that both
cytoplasmic and nuclear actin synergistically play an
important role in serum response factor-induced transcrip-
tion (Vartiainen et al. 2007), an experimental system that
can rule out cytoplasmic actin is useful. TheXenopus giant
Figure 6. Association of nuclear actin with chromatin proteins
and chromatin of transplanted nuclei. (A) Coimmunoprecipita-
tion analysis in GV lysates to examine binding of nuclear actin
to Pol II and the BAF complex. GV proteins were immunopre-
cipitated by IgG and antibodies against BAF57, BRG1, BAF53A,
and Pol II, and were analyzed by Western blots by probing for
b-actin and actin. Five percent input was loaded. (B) TOCA-1
overexpression enhances nuclear b-actin binding to the Oct4
gene. ChIP analysis using anti-bactin antibody was performed
with TOCA-1-overexpressed NT oocytes (Toca1+) and normal
NT oocytes (Toca1) 48 h after NT using RA-ES cells. The Oct4
gene regulatory region was expressed as distal enhancer (DE),
proximal enhancer (PE), and proximal promoter (PP). As a con-
trol, ChIP analysis using nonspecific IgG was carried out with
normal NT oocytes. The relative abundance of precipitated
DNA against total input DNA was measured by qPCR. Data
represent mean 6 SEM; n = 5.
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GV enables us to isolate it in a nonaqueous medium
without losing its transcriptional activity (Lund and Paine
1990; Jullien et al. 2010). Since reprogramming in an oil
GV relies on nuclear contents, the substantial inhibition of
gene reactivation by depolymerizing GV actin in this
system supports our conclusion.
Cytoplasmic actin filament formation and its proper
function are dependent on actin nucleators (Campellone
and Welch 2010). N-WASP, an actin nucleator, is present
in nuclei and makes a bridge between actin and Pol II
(Wu et al. 2006), but its function is largely autoinhibited.
Therefore, overexpression of N-WASP itself might not
have any effects on gene reactivation. Toca-1 is identified
as an upstream regulator of N-WASP to release this
inhibition (Ho et al. 2004), and faithfully enhances Oct4
reactivation in our experiments. The prominent effect
of Toca-1 on gene reactivation may be explained by its
characteristic as an upstream molecule in actin polymer-
ization signaling (Ho et al. 2004; Fricke et al. 2009). The
second strongest effect was induced by Rac1. Considering
that Rac1 and Toca-1 share the same downstream target
(N-WASP and SCAR/WAVE), these actin signaling path-
waysmay include an important step forOct4 reactivation.
Nuclear actin and the BAF complex were facilitated in
their binding to Oct4 by Toca-1. This is possibly because
Toca1-mediated actin polymerization near theOct4 gene
increased an opportunity for the BAF complex to be
bound at the area, resulting in an increased chance for
BAF to associate with chromatin. This model agrees with
a previous study showing that an actin signaling protein,
PIP2, allows the BAF complex to associate with polymer-
ized actin and chromatin (Zhao et al. 1998; Rando et al.
2002). The BAF complex opens chromatin by nucleosome
sliding or ejection (Cairns 2009). Importantly, BAF knock-
down induces down-regulation of Oct4 (Ho et al. 2009;
Kidder et al. 2009). This positive regulator presumably
converts chromatin into an accessible state for transcrip-
tional activators (Singhal et al. 2010), which may allow
general transcription factors to act onOct4 transcription.
Indeed, Pol II enhanced its association with theOct4 gene
in parallel with these events in our experiment. Toca-1-
induced actin polymerization might act upstream in this
series of reprogramming events.
Our experiments and previous reports show that nu-
clear actin is associated with regulatory regions of acti-
vating genes and is involved in selective gene activation
(Ferrai et al. 2009; Taylor et al. 2010; Xu et al. 2010).
Although the reason why only a subset of gene reactiva-
tions was affected by actin polymerization is still not clear,
one model for how actin selectively binds to specific
genomic sites can be proposed. WASP is supposed to be
recruited to DNA by interaction with the transcription
factor SP1 (Taylor et al. 2010). Such a recruited actin
nucleator can induce actin nucleation at this site, and
thus nuclear actin localization occurs at a specific region.
Interestingly, the SP1 site on the Oct4 promoter is neces-
sary for DNA demethylation and transcription (Simonsson
and Gurdon 2004). Recruitment of N-WASP and nuclear
actin on the SP1 site might be a necessary step for Oct4
transcriptional reprogramming.
We assume that nuclear actin-mediated reprogram-
ming is a comparatively late step in the whole transcrip-
tional reprogramming process in oocytes. The beginning
of reprogramming is characterized by a prompt incorpo-
ration of the embryonic linker histone B4 and loss of
somatic linker histone H1 (Jullien et al. 2010). Subse-
quently, gradual swelling of transplanted nuclei proceeds
and transcription starts ;24 h after NT. Notably, nuclear
actin starts to appear at approximately the same time as
transcription starts. As transcription increases toward
a peak level after further culture, an active histone mark
(histone H3K4 methylation) is added (Murata et al. 2010)
and more actin is detected in transplanted nuclei. To-
gether with these observations and our present results,
nuclear actin is likely to be implicated in the beginning of
the transcriptional initiation process and enhancement of
transcription. This fits with our results because nuclear
actin is associated with the BAF complex and Pol II; these
have crucial roles in transcriptional initiation and en-
hancement. This model is further supported by a recent
study showing that an actin nucleator binds to H3K4
trimethyltransferase RBBP5 and is important for its activ-
ity for activating genes (Taylor et al. 2010).
The role of nuclear actin has been elusive. Neverthe-
less, many attempts have revealed its novel function in
the nucleus, including transcription and physical gene
movement. Here we add a new function of nuclear actin
in transcriptional reprogramming. Moreover, our results
emphasize the significant contribution of nuclear actin
polymerization in transcriptional activation. The impor-
tance of G-actin in transcriptional regulation has been
shown clearly in a previous report (Vartiainen et al. 2007).
We therefore propose that both nuclear G- and F-actin are
involved in transcriptional regulation in different ways,
and the balance between those two forms of actin may be
important for regulating transcription. Massive amounts
of nuclear actin, which actively change its polymerized
states during reprogramming, are stored in the oocyte
nucleus. This helps to explain why an oocyte can repro-
gram multiple nuclei efficiently and rapidly.
Materials and methods
NT and mRNA injection
Xenopus oocytes were defolliculated with Liberase (05401127001,
Roche). Defolliculated oocytes were kept in modified Barth’s
solution (MBS) at 14°C before use. Mouse cells (ES, RA-ES, and
C2C12 cells) were permeabilized with 100 mg/mL Streptolysin O
(SLO) for 5–15 min at 37°C. Successful permeabilization (> 95%)
was confirmed by Trypan blue staining. Permeabilization was
stopped by the addition of modified Merriam’s medium (20 mM
HEPES at pH 7.5, 75 mM KCl, 2 mM MgCl2, 2% PVP, 2 mM
b-mercaptoethanol) containing BSA. These permeabilized cells
were suspended in modified Merriam’s medium with 1% BSA to
achieve a concentration of 250–300 nuclei per 10 nL, and 10 nL of
the cell suspension was injected into a Xenopus oocyte nucleus
(GV). In every experiment, calibration of the injected cell
number was performed to deliver a constant number of nuclei
to each oocyte. Successful injection was confirmed by dissecting
the injected oocytes, since injected nuclei can be observed under
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a microscope. The injected oocytes were cultured for up to 3 d at
16°C in MBS supplemented with 0.1% BSA and antibiotics.
Different volumes of mRNA, depending on an experiment,
were injected into oocytes equatorially. The mRNA injection
was performed 1 d before NT in order to accumulate the over-
expressed proteins in oocytes. Amounts of injected mRNAwere
as follows: GFP-UtrCH, 40.8 ng per 40.8 nL; b-actin-R62D/S14C/
G15S/G13R/wt-HA, 27.6 ng per 27.6 nL; xtJMY-HA, xtTocal-
HA,myc-hToca1(W518K), xtToca-1-Cherry-HA,mN-WASP-HA,
and xlRac1-HA, 13.8 ng per 13.8 nL; RFP-histone B4 and Cherry-
histone H2B, 4.6 ng per 4.6 nL or 1.5 ng per 4.6 nL.
Oil GV method
NT oocytes cultured in MBS were transferred onto a slide glass
and the MBS solution was removed as much as possible. The
oocytes were moved into mineral oil and GVs were dissected (oil
GVs). The dissected GVs were transferred onto a slide glass for
confocal microscope analysis. For the NT experiment into oil
GV, permeabilized cells (250–300 nuclei per 4.6 nL) were injected
into the dissected GV. Modified Merriam’s medium containing
50 mg/mLCB (Sigma), 5 mMLA (Sigma), or 0.5%DMSOwas used
for cell suspension. The injected GVs were cultured in mineral
oil for up to 2 d at 16°C.
Transcriptional reprogramming assay and qRT–PCR
For detecting reprogrammed transcripts from injected mouse
nuclei, qRT–PCR analysis was performed (Halley-Stott et al.
2010). Four whole injected oocytes (equivalent to 1000–1200
injected nuclei) or 10 injected oil GVs were pooled as one sample,
and RNAwas extracted from the samples using Qiagen RNeasy
columns. After RNA extraction, including on-column DNase I
digestion, reverse transcription was performed using SuperScript
III with gene-specific primers. Real-time PCR was performed as
SYBR green assays on an ABI 7300 Real-Time PCR Cycler using
standard ABI cycling condition. Primers used in this assay are
listed in Supplemental Table S1. Quantification was performed
using ES cell cDNA within the log-linear phase of the amplifica-
tion curve. The mean quantity was normalized to mouse Gapdh
transcripts (expressed as Oct4/Gapdh), or a relative transcript level
of every gene was listed.
Cell culture and transfection
Mouse ES cells were grown on gelatin-coated dishes in ESmedium
(GMEM, 20%ES-grade FBS [Invitrogen],MEMnonessential amino
acids, sodiumpyruvate, leukemia inhibitory factor [LIF] [Millipore;
ESGRO], b-mercaptoethanol, antibiotics) under feeder-free con-
dition. For retinoic acid differentiation, the ES medium was
changed to the differentiation medium (GMEM, 20% FBS
[Invitrogen], MEM nonessential amino acids, sodium pyruvate, 1
mM retinoic acid, b-mercaptoethanol, antibiotics). C2C12 cells
were maintained in DMEM containing 10% FBS, penicillin, and
streptomycin. Transfection was performed with Lipofectamine
2000 (Invitrogen) according to the vendor’s protocol. ES cells
were transfected with Lac repeats–Oct4 regulatory region–Neo,
and stably expressing cells were selected using G418. C2C12
cells were transiently transfected with the Cherry-laminB1
plasmid and used for NT.
Live-cell imaging, immunofluorescence, image analysis
GVs were dissected from injected oocytes in mineral oil. For
F-actin staining on fixed samples, GVs were dissected one by one
in GV isolation buffer (20 mM Tris-HCl at pH 7.5, 0.5 mM
MgSO4, 140 mM KCl), immediately transferred into 10% para-
formaldehyde containing 1 mM phalloidin-TRITC (Fulka), and
incubated for 20–25 min with gentle rotating. After washing
with PBS containing 0.2% Tween20, DNA was stained with
DAPI, followed by washing. For TOCA-1 staining, GVs were
permeabilized with PBS containing 0.5% Triton X and blocked
with PBS containing 5% FBS and 0.2% Tween20. Anti-Toca-1
antibody (a gift from J. Gallop and M. Kirschner) and anti-
phoPolII(S2) (cloneH5:MMS-129R, Covance) were used with
1:100 dilution, and anti-rabbit IgG Alexa Fluor 488 and anti-
mouse IgM Alexa Flour 633 were used as secondary antibodies
(1:200 dilution). Confocal analysis was carried out on a Zeiss 510
META confocal LSM microscope equipped with argon (488 nm),
HeNe (543 and 637 nm), and MaiTai (740 nm) lasers. For time-
lapse experiments, images were taken every 10 min, and these
were projected using Zeiss LSM 510 software.
Nuclear actin in transplanted nuclei was quantified by ImageJ
software. F-actin was labeled with phalloidin-TRITC and nuclei
were labeled with DAPI. By using the straight-line selection tool,
a line was drawnwithin a transplanted nucleus whose area could
be judged by DAPI staining. Strong dot-like staining was avoided
when drawing the line. Mean signal intensities in the plotted
areas were calculated by the Analyze tool. More than nine NT
oocytes were used for the analysis, and five images of trans-
planted nuclei were selected randomly from each NT oocyte.
qChIP
ChIP analysis was performed as described previously with modi-
fications (Astrand et al. 2009; Jullien et al. 2010). NToocytes that
contain ;300 mouse nuclei per oocyte were transferred to MBS
medium without BSA, and then a set of seven to 10 oocytes was
transferred into a 1.5-mL tube. After washing with MBS, NT
oocytes were cross-linked for 10 min at room temperature in
1 mL of MBS medium containing 1% formaldehyde, with gentle
shaking. Fixation was stopped by rapid washing of oocytes in
MBS. The oocytes were ruptured in 280 mL of homogenization
buffer (50mMHEPES at pH 7.8, 140mMNaCl, 1mMEDTA, 1%
Triton X-100, 0.1% sodium deoxycholate, 0.3% SDS, 1 mM
DTT, protease inhibitors) by pipetting and kept on ice before
sonication. Sonication was carried out in 1.5-mL tubes for 7 min
twice with a 30-sec on/30-sec off cycle by Bioruptor TWIN
(Diagenode). Six-hundred microliters of buffer I (50 mM HEPES
at pH 7.8, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1%
sodium deoxycholate, 1 mM DTT, protease inhibitors) was
added to the sonicated samples. These solutions from two tubes
were mixed in 2-mL tubes, finally yielding 1800 mL. The samples
were centrifuged at 13,000 rpm at 4°C. Supernatants were
transferred, and 10% of these supernatants was taken as inputs
and mixed with an equal volume of 23 Stop buffer (40 mM Tris-
HCl at pH 8.0, 10 mM EDTA, 1% SDS) and 0.3 mg/mL proteinase
K (final concentration). The inputs were incubated overnight at
65°C. The rest of the sonicated solution was mixed with anti-
body and incubated overnight at 4°C with rotation. The anti-
bodies used here were 3 mL of mouse monoclonal anti-bactin
(cloneAC15:A1978, Sigma), 2 mL of goat polyclonal anti-BAF57
(ab14764, Abcam), 1 mL ofmousemonoclonal anti-Pol II[8WG16]
(ab817, Abcam), 2 mL of rabbit IgG (sc2027, Santa Cruz Bio-
technology), and 1 mL of rabbit polyclonal anti-Histone H3
(ab1791, Abcam). After antibody reaction, 20 mL of dynabeads
protein G (Invitorgen) was added and was rotated for another 6 h
at 4°C. The bead antibody conjugates were washed in the
following order with buffer I, buffer II (50 mM HEPES at pH
7.8, 500 mMNaCl, 1 mM EDTA, 1%Triton X-100, 0.1% sodium
deoxycholate, 1 mMDTT, protease inhibitors), buffer III (20 mM
Tris-HCl at pH 8.0, 1 mM EDTA, 250 mM LiCl, 0.5% NP40,
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0.5% sodium deoxycholate, 1mMDTT, protease inhibitors), and
TE containing 1 mM DTT and protease inhibitors for 30 min at
4°C with rotation. After the last washing, 150 mL of 13 Stop
buffer with 0.3 mg/mL proteinase K was added to the beads, and
cross-links were reversed by incubation overnight at 65°C. DNA
was isolated from inputs and immunoprecipitates. The DNA
was finally resuspended in 50 mL of elution buffer. Four micro-
liters was used for qPCR analysis. When abundant chromatin
proteins like core histones were precipitated, 10 NT oocytes
(equivalent to 3000 injected nuclei) were enough to detect
signals. However, other cases like nuclear actin required 14–20
NT oocytes (equivalent to 4200–6000 injected nuclei). We used
a transgenic ES cell line that possesses ;30 copies of the Oct4
regulatory region as a donor cell in order to increase the strength
of the signals. The relative abundance of precipitated DNA
against total input DNAwas measured by qPCR, and this value
is expressed as signal per a single gene copy. In every ChIP
analysis, anti-histone H3 antibody was used as a positive control
to check whether precipitation was carried out successfully.
Coimmunoprecipitation and immunoprecipitation analysis
Ten GVs per coimmunoprecipitation were collected in immu-
noprecipitation buffer (20 mM HEPES at pH 7.5, 5 mM KCl,
1.5 mMMgCl2, 1 mM EGTA, 150 mMNaCl, 0.1% NP40, 1 mM
DTT, 0.2 mM PMSF, protease inhibitor cocktail). The GVs in
10 mL of immunoprecipitation buffer were transferred into tubes
and disrupted by pipetting up and down. One microliter was
taken as an input, and 1–3 mL of the following antibodies were
added: mouse monoclonal anti-GFP (11814460001, Roche), rab-
bit IgG, goat polyclonal anti-BAF57, rabbit polyclonal anti-
BAF53A (ab3882, Abcam), rabbit polyclonal anti-BRG1 (A300-
813A, Bethyl Laboratories), and mouse monoclonal anti-Pol
II[8WG16]. After incubating overnight at 4°C, Dynabeads Pro-
tein G was added and incubated for 30 min at room temperature.
The beads were washed with immunoprecipitation buffer and
binding proteins were extracted for Western blots. Immunopre-
cipitation of Toca-1 from GV extracts was carried out as de-
scribed previously (Ho et al. 2004) and the extracts were obtained
from 50 GVs.
Nuclear actin fractionation
Thirty GVs were collected in mineral oil in order to minimize
artificial changes in actin polymerization. The GVs were trans-
ferred into an ultracentrifuge tube and 500 mL of lysis and F-actin
stabilization buffer (50 mM PIPES at pH 6.9, 50 mMNaCl, 5 mM
MgCl2, 5 mM EGTA, 5% glycerol, 0.1% NP40, 0.1% Triton
X-100, 0.1% Tween20, 0.1% b-mercaptoethanol, 1 mM ATP,
protease inhibitor cocktail) was added. GVs were disrupted by
pipetting up and down and the lysate was centrifuged at 100,000g
for 1 h at 23°C. The supernatant was transferred immediately
into another tube and was used as the G-actin fraction. The
pellet was resuspended in 500 mL of ice-cold water containing
100 mMCB and kept on ice for 30 min with some pipetting. After
the incubation, samples were sonicated with probe sonicator and
used as the F-actin fraction. Total amounts of b-actin or total
actin were measured by the Western blot analysis.
Western blots
Western blots were performed following standard protocols.
Anti-mouse, anti-rabbit, or anti-goat IgG Alexa Fluor 680
(Invitrogen) was used as a secondary antibody, and bands were
detected using the LI-COR ODYSSEY imaging system. Primary
antibodies used were as follows: rabbit polyclonal anti-Toca1
(a gift from J. Gallop and M. Kirschner), mouse monoclonal anti-
b-actin (cloneAC15), rabbit polyclonal anti-actin (A2103, Sigma),
rabbit polyclonal anti-Histone H2B (ab1790, Abcam), mouse
monoclonal anti-GFP, mouse monoclonal anti-HA (H9658,
Sigma), and rabbit polyclonal anti-HA (ab9110, Abcam).
Plasmid construction and RNA synthesis
Actin mutants (Posern et al. 2002, 2004) were subcloned from
original reported vectors into Gateway vectors (pCS2-b-actin-
[R62D/S14C/G15S/G13R/wt]-HA). Xenopus tropicalis jmy, X.
tropicalis Toca-1 (fnbp1l), mouse N-WASP (Wasl), and X. laevis
rac1 were cloned into pCS2-HA and/or pCS2-Cherry-HA. pCS2-
Cherry-hH2B and pCS2-RFP-histoneB4 were produced previ-
ously in our laboratory (Jullien et al. 2010). p3216PECMS2
(Janicki et al. 2004), pCS2-GFP-UtrCH (Burkel et al. 2007), and
pCMV-CuO-lacI-mCherry-laminB1 (Kumaran and Spector 2008)
were gifts. For producing Oct4 regulatory region–Neo cell lines,
the p3216PECMS2 plasmid was modified. The inducible CMV
promoter was swapped with the murine Oct4 3.6-kb upstream
region and the CFP reporter was changed to the Neomycin-
resistant gene. This plasmid was transfected to ES cells. In vitro
synthesized mRNAs were produced with MEGAscript SP6
(AM1330, Ambion).
Statistic analysis
The number of biological replicates are shown as n. In transcrip-
tional assays, technical duplicates were performed on all sam-
ples and an average of the duplicate was regarded as the value of
one sample. Statistic difference was calculated by F and T-test
(P < 0.05). Error bars were represented as standard error.
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